Navigation Links
Biomerix Corporation Announces FDA Clearance and Market Launch of REVIVE(TM) for Use in Soft Tissue Repair Procedures
Date:2/26/2009

FREMONT, Calif., Feb. 26 /PRNewswire/ -- Biomerix Corporation announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market REVIVE(TM). Constructed using the Biomerix Biomaterial(TM), REVIVE acts as a tissue scaffold facilitating rapid tissue ingrowth and can be utilized in a variety of soft tissue repair procedures, including the repair of inguinal hernias.

With more than 700,000 procedures per year, inguinal hernia repair is one of the most common surgeries in the U.S.(1) Hernia repair typically involves the use of a mesh to reinforce and support the surrounding tissue. REVIVE is designed to minimize the scarring response that results from implantation of a mesh, which studies have shown can lead to persistent groin pain in 30% of patients at one year(2). Clinical feedback has confirmed REVIVE offers excellent conformability to the defect and ease of handling.(3)

"Biomerix is poised for rapid growth over the course of the next few years. The company plans to launch numerous products across a range of therapeutic areas by capitalizing on its novel Biomerix Biomaterial platform technology. REVIVE is specifically designed to support tissue remodeling by enhancing the soft tissue wound healing process and thereby improves clinical outcomes," stated Kenneth G. Hayes, President and Chief Executive Officer of Biomerix Corporation.

The company has initiated a market launch of REVIVE in the U.S. through a small direct sales force and plans to expand the group over time as additional products are brought to market.

About Biomerix Corporation

Biomerix Corporation develops and manufactures a broad portfolio of implantable medical devices based on its proprietary Biomerix Biomaterial(TM) platform technology. Unique to the Biomerix Biomaterial, is its ability to facilitate fibrovascular tissue in-growth and improve wound healing with a minimal inflammatory response, leading to better clinical outcomes. Biomerix strives to improve patient outcomes through the development of medical devices for soft tissue repair, neurovascular embolization, spine annular repair, cardiovascular repair and women's health indications, utilizing its novel biomaterial.

For more information please call 888.308.3620 or visit www.biomerix.com.

  1. Millenium U.S. Markets for Soft Tissue Repair 2008.
  2. Bay-Nielsen M et. al., "Pain and functional impairment 1 year after inguinal herniorrhaphy: a nationwide questionnaire study," Ann Surg 2001 Jan;233(1):1-7.
  3. Data on file with Biomerix Corporation


'/>"/>
SOURCE Biomerix Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
2. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
3. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
4. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
5. BioElectronics Corporation Announces Singapore and Malaysia Sales
6. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
7. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
8. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
9. Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference
10. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
11. Enova Medical Launches Exos Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2017)... ... , ... Tunnell Consulting has been solving the most complex problems ... faced by life sciences, biotech and pharmaceuticals companies today is in interpreting the complicated ... who is well known in the industry and brings significant high-level expertise to the ...
(Date:6/16/2017)... ... ... CTNext , Connecticut’s go-to resource for entrepreneurial support, today announced the ... Piers in Stamford. , Nine finalists, all of whom are Connecticut-based companies and entrepreneurs, ... secure $10,000 awards to help support business growth. The winners included:, ...
(Date:6/15/2017)... ... June 15, 2017 , ... ... promising new medical device startup. Dan Parsley, angelMD’s SVP of Corporate Development, served ... and this angelMD syndicate is part of Saranas’ recently announced $4 million Series ...
(Date:6/14/2017)... Bangkok, Thailand (PRWEB) , ... June 14, 2017 ... ... Thailand Center of Excellence for Life Sciences (TCELS) announces that they’re co-hosting a ... 19-22, 2017. , BIO, the largest biotech industry gathering in the world, ...
Breaking Biology Technology:
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
(Date:3/24/2017)... MILAN , March 24, 2017 The Controller ... Deputy Controller Mr. Abdulla Algeen have received the prestigious international ... Continue Reading ... ... small picture) and Deputy Controller Abdulla Algeen (small picture on the right) ...
(Date:3/22/2017)... 2017 Optimove , provider of ... such as 1-800-Flowers and AdoreMe, today announced two ... Replenishment. Using Optimove,s machine learning algorithms, these features ... replenishment recommendations to their customers based not just ... customer intent drawn from a complex web of ...
Breaking Biology News(10 mins):